| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Harold Jacob last filed a Form 4 in December 2024, as Director at ORMP. Harold Jacob's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 16,396 shares of ORMP. The ORMP filings lean toward selling, a net 8,500 shares.
Harold Jacob has 6 Form 4 filings on record from February 2015 to December 2024, across 2 companies: Chief Medical Officer at ENvue Medical (FEED), 2021–2024; Director at Oramed Pharmaceuticals (ORMP), 2015–2016.
The 8 reported transactions were 4 option or other derivative awards, 2 dispositions back to the company, 1 open-market sale and 1 stock award.
Counted by filing, the open-market trades come to no purchases and 1 sale worth about $55K.
The only open-market sale was 8,500 shares of ORMP at an average $6.45 on March 10, 2016, about $55K.
Shares as reported in the last Form 4 for each company; the most recent is from December 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 10, 2016 | ORMP Oramed Pharmaceuticals Inc. | Director | Sell | 8,500 | $6.45 | $54,842.00 | -34.1% |